Hartford Investment Management Co (HIMCO)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
BPC
DLA
LIM
OIAM
LSA
Hartford Investment Management Co (HIMCO)'s MRNA Position: Q2 2026 in Review
Hartford Investment Management Co (HIMCO) reduced its Moderna (MRNA) stake by 3.1% in Q2 2026, selling an estimated $32K and leaving 19,361 shares worth $1.36M. The position accounts for 0.04% of the portfolio, ranked #343.
Hartford Investment Management Co (HIMCO) first reported a position in MRNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $13M in Q3 2021. 335 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Hartford Investment Management Co (HIMCO) held 19,361 shares of Moderna worth $1.36M as of Q2 2026.
- Hartford Investment Management Co (HIMCO) sold 619 Moderna shares in Q2 2026, an estimated $32K.
- Moderna made up 0.04% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #343 holding.
- Hartford Investment Management Co (HIMCO) first reported a position in Moderna in Q3 2021 and has held it in 20 quarters since.
- Hartford Investment Management Co (HIMCO)'s Moderna position peaked at $13M in Q3 2021.
- 335 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.